Asia Healthcare Holdings (AHH), an operating platform for single specialty healthcare in India and South Asia, on Tuesday announced the appointment of Arvind Sivaramakrishnan as its chief technology officer.

The appointment reinforces AHH’s commitment to transforming patient care through data-driven, technology-enabled healthcare delivery across its portfolio of single specialty healthcare enterprises, the company said.

Sivaramakrishnan, who comes with experience in driving enterprise-scale digital health transformation, will lead AHH’s digital technology strategy, overseeing digital infrastructure, artificial intelligence (AI) integration, cybersecurity, telehealth platforms and electronic health record optimisation across its verticals.

“Technology is the biggest enabler of healthcare access, quality and continuity today,” said Sivaramakrishnan. “At AHH, we are uniquely positioned to lead this technology transformation across all our current specialised verticals like women and childcare, fertility, urology and nephrology, and future growth areas.”

Sivaramakrishnan began his journey with Ramco Systems and later served as principal leader at DXC Technology (formerly Computer Sciences Corporation), where he led the clinical applications portfolio for Henry Ford Health Systems in Detroit, Michigan. In 2011, he returned to India to take on the role of group chief information officer at Apollo Hospitals, where he spearheaded digital transformation initiatives for more than a decade.

Most recently, he was chief information officer at Karkinos Healthcare.“We believe that digital-first healthcare institutions can create exponential impact on patient care and data can drive multiple levers of operating efficiency. We are delighted to welcome Arvind to our senior leadership team at AHH to create the blueprint of our technology road map and drive the multiple tech led initiatives on the platform,” said Vishal Bali, executive chairman, Asia Healthcare Holdings.AHH is backed by global investment firms GIC and TPG, and has established a portfolio of healthcare brands across oncology, women and childcare (Motherhood Hospitals), fertility and reproductive medicine (Nova IVF Fertility), and urology and nephrology (Asian Institute of Nephrology and Urology).